Risperidone is a psychotropic agent indicated for the treatment of acute and chronic schizophrenia. It demonstrates particular efficacy in managing both positive and negative symptoms, as well as comorbid affective symptoms such as anxiety and depression. Additionally, it alleviates emotional disturbances associated with schizophrenia. For patients who achieve stabilization during the acute phase, risperidone sustains its clinical benefits during the maintenance phase of treatment.

AccuSift provides high-performance competitive antibody pairs for risperidone detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 0.1 ng/mL